Dysregulation of septin cytoskeletal organization in the trabecular meshwork contributes to ocular hypertension
Rupalatha Maddala,Pallavi Gorijavolu,Levi K. Lankford,Nikolai P. Skiba,Pratap Challa,Rakesh K. Singh,K. Saidas Nair,Hélène Choquet,Ponugoti V. Rao
DOI: https://doi.org/10.1172/jci.insight.179468
IF: 9.4958
2024-12-08
JCI Insight
Abstract:Ocular hypertension, believed to result partly from increased contractile activity, cell adhesive interactions, and stiffness within the trabecular meshwork (TM), is a major risk factor for glaucoma, a leading cause of blindness. However, the identity of molecular mechanisms governing organization of actomyosin and cell adhesive interactions in the TM remains limited. Based on our previous findings, in which proteomics analyses revealed elevated levels of septins, including septin-9 in human TM cells treated with the ocular hypertensive agent dexamethasone, here, we evaluated the effects of septin-9 overexpression, deficiency, and pharmacological targeting in TM cells. These studies demonstrated a profound impact on actomyosin organization, cell adhesion, contraction, and phagocytosis. Overexpression raised intraocular pressure (IOP) in mice, while inhibition increased cell permeability. In addition, we replicated a significant association between a common variant (rs9038) in SEPT9 with IOP in the Genetic Epidemiology Research on Adult Healthy and Aging (GERA) cohort. Collectively, these data reveal a link between dysregulated septin cytoskeletal organization in the TM and increased IOP, likely due to enhanced cell contraction, adhesive interactions, and fibrotic activity. This suggests that targeting the septin cytoskeleton could offer a novel approach for lowering IOP in patients with glaucoma.
medicine, research & experimental
What problem does this paper attempt to address?